[1]
P. Sfriso, F. Salaffi, S. Bombardieri, B. Canesi, C. Montecucco, and S. Todesco, “The risk/benefit profile of biologic drugs in real-world rheumatology practice. From ANTARES to MonitorNet”, Reumatismo, vol. 60, no. 2, pp. 77-84, 1.